These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oxidative stress-linked biomarkers in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Paliogiannis P; Fois AG; Collu C; Bandinu A; Zinellu E; Carru C; Pirina P; Mangoni AA; Zinellu A Biomark Med; 2018 Oct; 12(10):1175-1184. PubMed ID: 30191745 [TBL] [Abstract][Full Text] [Related]
3. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin. Veith C; Drent M; Bast A; van Schooten FJ; Boots AW Toxicol Appl Pharmacol; 2017 Dec; 336():40-48. PubMed ID: 28987380 [TBL] [Abstract][Full Text] [Related]
4. Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. Markart P; Luboeinski T; Korfei M; Schmidt R; Wygrecka M; Mahavadi P; Mayer K; Wilhelm J; Seeger W; Guenther A; Ruppert C Antioxid Redox Signal; 2009 Feb; 11(2):227-40. PubMed ID: 18783310 [TBL] [Abstract][Full Text] [Related]
5. Romo1 expression contributes to oxidative stress-induced death of lung epithelial cells. Shin JA; Chung JS; Cho SH; Kim HJ; Yoo YD Biochem Biophys Res Commun; 2013 Sep; 439(2):315-20. PubMed ID: 23867822 [TBL] [Abstract][Full Text] [Related]
6. Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis. Rodriguez LR; Bui SN; Beuschel RT; Ellis E; Liberti EM; Chhina MK; Cannon B; Lemma M; Nathan SD; Grant GM Mol Med; 2019 Jun; 25(1):27. PubMed ID: 31195971 [TBL] [Abstract][Full Text] [Related]
7. Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis. Tsubouchi K; Araya J; Yoshida M; Sakamoto T; Koumura T; Minagawa S; Hara H; Hosaka Y; Ichikawa A; Saito N; Kadota T; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Hashimoto M; Wakui H; Numata T; Kaneko Y; Mori S; Asano H; Matsudaira H; Ohtsuka T; Nakayama K; Nakanishi Y; Imai H; Kuwano K J Immunol; 2019 Oct; 203(8):2076-2087. PubMed ID: 31534007 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. Walters DM; Cho HY; Kleeberger SR Antioxid Redox Signal; 2008 Feb; 10(2):321-32. PubMed ID: 17999635 [TBL] [Abstract][Full Text] [Related]
10. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling. Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Fois AG; Paliogiannis P; Sotgia S; Mangoni AA; Zinellu E; Pirina P; Carru C; Zinellu A Respir Res; 2018 Mar; 19(1):51. PubMed ID: 29587761 [TBL] [Abstract][Full Text] [Related]
12. Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis. Estornut C; Milara J; Bayarri MA; Belhadj N; Cortijo J Front Pharmacol; 2021; 12():794997. PubMed ID: 35126133 [TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and regulation of glutathione in lung inflammation. Rahman I; MacNee W Eur Respir J; 2000 Sep; 16(3):534-54. PubMed ID: 11028671 [TBL] [Abstract][Full Text] [Related]
14. Mitigation of Oxidative Stress in Idiopathic Pulmonary Fibrosis Through Exosome-Mediated Therapies. Wang Z; Zhang Y; Li X Int J Nanomedicine; 2024; 19():6161-6176. PubMed ID: 38911503 [TBL] [Abstract][Full Text] [Related]
15. Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis. Chilosi M; Doglioni C; Murer B; Poletti V Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):7-18. PubMed ID: 21086900 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis. Bargagli E; Refini RM; d'Alessandro M; Bergantini L; Cameli P; Vantaggiato L; Bini L; Landi C Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784632 [TBL] [Abstract][Full Text] [Related]
18. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Milara J; Navarro R; Juan G; Peiró T; Serrano A; Ramón M; Morcillo E; Cortijo J Thorax; 2012 Feb; 67(2):147-56. PubMed ID: 22106015 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in particulate-induced pulmonary fibrosis; for the application of possible strategy experimentally and clinically. Kim KA; Park CY; Lim Y; Lee KH Curr Drug Targets; 2000 Nov; 1(3):297-307. PubMed ID: 11465077 [TBL] [Abstract][Full Text] [Related]
20. Involvement of 4-hydroxy-2-nonenal in the pathogenesis of pulmonary fibrosis. Reyes-Jiménez E; Ramírez-Hernández AA; Santos-Álvarez JC; Velázquez-Enríquez JM; Pina-Canseco S; Baltiérrez-Hoyos R; Vásquez-Garzón VR Mol Cell Biochem; 2021 Dec; 476(12):4405-4419. PubMed ID: 34463938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]